# TRIFLURIDINE; TIPIRACIL
> **ANDA214036** · Abbreviated New Drug Application (Generic) · Sponsor: INTAS PHARMS LTD · Approved 2022-10-13
## Drug
- **FDA Application Number:** ANDA214036
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRIFLURIDINE; TIPIRACIL
- **Generic name:** Trifluridine
- **Active ingredients:** TRIFLURIDINE; TIPIRACIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** INTAS PHARMS LTD
- **First approval:** 2022-10-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214036)
---
*MORVS · CC0 1.0*